
Sindhoori Surgicals & Pharma Private Limited
Manufactures pharmaceuticals, medical chemicals, and botanical products.
Manufactures pharmaceuticals, medical chemicals, and botanical products.
Sindhoori Surgicals & Pharma Private Limited (SSPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 June 2020 (Four years and eight months 26 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Nikhileswar Gari, Susmitha Gopireddy, Aruna Nallaiahgari, and One other member serve as directors at the Company.
Rangareddy, Telangana, India
+91-XXXXXXXXXX
U85100TG2020PTC140879
140879
Private Limited Indian Non-Government Company
16 Jun 2020
30 Sep 2024
31 Mar 2024
Unlisted
Roc Hyderabad
Sindhoori Surgicals & Pharma Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Rehabilitation Equipment, Wheel Chairs, Crutches and Walker, Walking Aids, Exercise Bikes & Fitness Equipments, Ellipticals, Crutches, Movable Walker, Rehab Immobilizers, Furniture Fittings & Hardware.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nikhileswar Gari ![]() | Director | 25-Nov-2022 | Current |
Susmitha Gopireddy ![]() | Director | 16-Jun-2020 | Current |
Aruna Nallaiahgari ![]() | Director | 16-Jun-2020 | Current |
Parvathi Gopireddy ![]() | Director | 25-Nov-2022 | Current |
Sindhoori Surgicals & Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 4048.94% increase in profit. The company's net worth Soared by an impressive increase of 54067.13%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Sindhoori Surgicals & Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Nikhileswar Gari and Susmitha Gopireddy are mutual person
Parvathi Gopireddy is a mutual person
₹10.00 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
22 Jun 2023 | Hdfc Bank Limited | ₹1.50 M | Open |
20 Jul 2022 | Hdfc Bank Limited | ₹8.50 M | Open |
Sindhoori Surgicals & Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sindhoori Surgicals & Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sindhoori Surgicals & Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sindhoori Surgicals & Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Sindhoori Surgicals & Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
A charge with Hdfc Bank Limited amounted to Rs. 1.50 M with Charge ID 100772189 was registered on 22 Jun 2023.
A charge with Hdfc Bank Limited of Rs. 8.50 M registered on 20 Jul 2022 with Charge ID 100605631 was modified on 22 Jun 2023.
Nikhileswar Reddy Nallaiah Gari was appointed as a Director was appointed as a Director on 25 Nov 2022 & has been associated with this company since 2 years 3 months .
Parvathi Gopireddy was appointed as a Director was appointed as a Director on 25 Nov 2022 & has been associated with this company since 2 years 3 months .
Sindhoori Surgicals & Pharma Private Limited was incorporated on 16 Jun 2020.
The authorized share capital of Sindhoori Surgicals & Pharma Private Limited is ₹ 2.00 M and paid-up capital is ₹ 2.00 M.
Currently 4 directors are associated with Sindhoori Surgicals & Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sindhoori Surgicals & Pharma Private Limited is 8-4-300/1/A A416 Kalpataru Residency Prem Nagar Erragadda, Yousufguda India, Hyderabad, Telangana, 500018.
The corporate identification number (CIN) of Sindhoori Surgicals & Pharma Private Limited is U85100TG2020PTC140879 and the company number is 140879 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2023 indicates that The net worth of Sindhoori Surgicals & Pharma Private Limited has experienced an upsurge of 54067.13%.
As per the financial statements for fiscal Year 2023, The total open charges for Sindhoori Surgicals & Pharma Private Limited amount to ₹ 1.00 Cr.
The most recent Balance Sheet for Sindhoori Surgicals & Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.